MannKind Corp (MNKD) Peer Comparison

$4.09

$-0.07 (-1.68%)

As on 26-Aug-2026 16:27EDT

Market cap

$1,334 Mln

Revenue (TTM)

$394 Mln

P/E Ratio

--

P/B Ratio

187.9

Div. Yield

0 %

Edit

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	1,334	16,614	17,326	13,400	12,305
Revenue ($ Mln)	394	1,054	2,782	2,436	670
Net Profit ($ Mln)	-43.61	755.85	491.50	860.62	-319.95
Net Margin (%)	-11.08	71.69	17.67	35.33	-47.79
RoE (%)	--	--	110.09	42.98	-71.14
Price to Earnings	--	19.38	36.49	17.01	--
Price-To-Book	187.85	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	393.63	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	95.70	103.47	1,982.07	85.67	19.14
Gross Profit	287.81	588.53	760.62	2,236.43	829.45
Operating Expenses	290.17	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	7.75	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-48.65	101.11	598.92	1,035.47	-252.08
Provision for Tax	-5.04	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-43.61	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	-67.20	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	656.60	384.48	187.89	288.55	1,362.63
Current Liabilities	142.90	464.70	1,435.43	361.93	283.35
Total Liabilities	792.18	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	486.59	895.24	1,006.90	1,243.41	440.60
Current Assets	245.71	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	792.18	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	330.85	449.89	120.10	165.93	864.07
Net Current Assets	102.81	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	18.26	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	-304.80	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	315.10	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	3.00	-30.01	53.56	32.82	-0.17
ROE (%)	-9.03	163.18	110.09	42.98	-71.14
ROA (%)	-6.24	26.53	15.64	29.32	-16.12
EBIT Margin (%)	2.53	5.73	21.13	31.04	-0.77
Net Margin (%)	-11.08	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	30.46	114.85	24.67	9.23	12.22
EBIT Growth (%)	-85.49	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	-232.98	378.76	17.50	42.89	-115.58
EPS Growth (%)	-228.70	353.27	26.84	50.42	-73.87
Book Value Growth (%)	-22.99	816.12	164.02	-0.70	-13.57

Valuation Ratios

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	303.77	-59.76	36.06	15.79	-2,869.63
Price / Book Value	-34.91	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	75.69	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	-4.75	0.00	0.00	0.00	1.77
Short term debt to equity ratio	-0.03	0.05	0.00	0.00	0.09
Current Ratio	1.72	2.99	0.73	3.46	5.90
Quick Ratio	1.41	2.32	0.73	3.38	5.90
Interest Coverage	-0.09	1.62	--	--	-1.72

Operating Efficiency Ratios

	MannKind Corp (MNKD)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	10.98	21.25	15.88	13.74	1.28
Asset Turnover	0.56	0.37	0.89	0.83	0.34
Receivable days	26.26	85.52	50.42	43.48	1.50
Inventory Days	188.71	1,056.70	--	96.17	--
Payable days	47.26	331.01	6.26	147.97	221.81
Cash Conversion Cycle	167.71	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly